 |
Iyabode Akinsanya-Beysolow,
MD, MPH
Iyabode Akinsanya-Beysolow, MD, MPH
Medical Officer
Centers for Disease Control and Prevention
National Center for Immunization and Respiratory Disease
Atlanta, GA
This faculty member participated in the following program(s)
“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”
Paul G. Auwaerter,
MD, MBA, FACP, FIDSA
Paul G. Auwaerter, MD, MBA, FACP, FIDSA
Associate Professor of Medicine Johns Hopkins University School of Medicine
Chief Medical Officer, Point of Care-Information Technology (POC-IT) Center Johns Hopkins University School of Medicine Baltimore, MD
This faculty member participated in the following program(s)
“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”
“Community-acquired MRSA: Managing These Puzzling Bacteria”
“Candida and Cryptococcus: The Epidemiology, Diagnosis, and Treatment of Medically Important Yeast”
“Aspergillus and Fusarium: The Epidemiology, Diagnosis, and Treatment of Medically Important Molds”
“Skin and Soft Tissue Infections in Patients with Diabetes, including Cellulitis, Ulcers, and Osteomyelitis”
“Epidemiology, Diagnosis, and Treatment in the Era of Community Onset MRSA, Prevention and Management of a Recurrent Infection”
“Identification and Treatment of Community-Associated MRSA”
“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”
John G. Bartlett,
MD
John G. Bartlett, MD
Professor
Johns Hopkins University School of Medicine
Division of Infectious Diseases
This faculty member participated in the following program(s)
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on Antibiotics and Vaccines”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on HIV”
“Clinical Updates from the 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention”
“Clinical Updates in the Management of HIV from the 49th ICAAC® Conference”
"Initiation of Antiretroviral Therapy for HIV: Insights and Rationale"
“Management of the Treatment Experienced Patient with HIV Infection”
“Highlights from the 19th Conference on Retroviruses and Opportunistic Infections: CROI in Context”
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”
Todd T. Brown,
MD, Phd
Michael A. Chattergoon,
MD, PhD
Michael A. Chattergoon, MD, PhD
Fellow, Division of Infectious Diseases
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Community-acquired MRSA: Managing These Puzzling Bacteria”
“Identification and Treatment of Community-Associated MRSA”
Joseph Cofrancesco Jr.,
MD, MPH, FACP
Joseph Cofrancesco Jr., MD, MPH, FACP
Associate Professor of Medicine
Director, Johns Hopkins Lipodystrophy and Metabolic Complications Clinic
Medical Director, HIV Services, The Rockland Physicians Group at Green Spring Station
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Assessing and Managing Cardiovascular Risk in Patients with HIV”
“Management of Intersecting Epidemics: Metabolic Disorders and Liver Disease in HIV”
“HIV-Associated Lipoatrophy – Management and Treatment Considerations”
Calvin J. Cohen,
MD, MSc
Calvin J. Cohen, MD, MSc
Clinical Instructor of Medicine
Harvard Medical School
Research Director, Harvard Vanguard Medical Associates
Director of Research, Community Research Initiative of New England
This faculty member participated in the following program(s)
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011”
“Clinical Updates in the Management of HIV from the 49th ICAAC® Conference”
“HIV-Associated Lipoatrophy – Management and Treatment Considerations”
Sara E. Cosgrove,
MD, MS
Sara E. Cosgrove, MD, MS
Assistant Professor, Department of Medicine, Division of Infectious Diseases
Director, Antibiotic Management Program
Associate Hospital Epidemiologist
Johns Hopkins Medical Institutions
This faculty member participated in the following program(s)
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on Antibiotics and Vaccines”
“Skin and Soft Tissue Infections in Patients with Diabetes, including Cellulitis, Ulcers, and Osteomyelitis”
“Epidemiology, Diagnosis, and Treatment in the Era of Community Onset MRSA, Prevention and Management of a Recurrent Infection”
Joel E. Gallant,
MD, MPH
Joel E. Gallant, MD, MPH
Professor of Medicine, Division of Infectious Diseases
Johns Hopkins University School of Medicine
Professor of Epidemiology, Johns Hopkins Bloomberg School of Public Health
Associate Director, Johns Hopkins AIDS Service
This faculty member participated in the following program(s)
“Management of Intersecting Epidemics: Metabolic Disorders and Liver Disease in HIV”
“Initiation of Antiretroviral Therapy for HIV: Insights and Rationale”
“Management of the Treatment Experienced Patient with HIV Infection”
Amita Gupta,
MD, MHS
Amita Gupta, MD, MHS
Deputy Director of the Johns Hopkins University Center for Clinical Global Health Education
Assistant Professor of Infectious Diseases
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Clinical Updates from the 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention”
Lawrence Herman,
MPA, RPA-C, DFAAPA
Lawrence Herman, MPA, RPA-C, DFAAPA
Physician Assistant
Academic Coordinator
Assistant Professor
Department of Physician Assistant Studies
New York Institute of Technology
Old Westbury, NY
This faculty member participated in the following program(s)
“Understanding and Implementing Hepatitis A, Influenza, Pneumococcus, and Rotavirus Vaccination in Infants and Young Children”
Charles Hicks,
MD
Charles Hicks, MD
Associate Professor of Medicine, Division of Infectious Diseases
Duke University Medical Center
This faculty member participated in the following program(s)
“Clinical Updates from the 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention”
“Management of the Treatment Experienced Patient with HIV Infection”
Christopher Hoffmann,
MD, MPH
Christopher Hoffmann, MD, MPH
Assistant Professor
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Johns Hopkins AIDS Services
This faculty member participated in the following program(s)
“Assessing and Managing Cardiovascular Risk in Patients with HIV”
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011”
“Highlights from the 19th Conference on Retroviruses and Opportunistic Infections: CROI in Context”
Rita Rastogi Kalyani,
MD, MHS
Rita Rastogi Kalyani, MD, MHS
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”
Rebecca A. Kazin,
MD
Rebecca A Kazin, MD
Assistant Professor of Dermatology
Johns Hopkins University School of Medicine
Medical Director of the Johns Hopkins Cosmetic Center at Greenspring Station
This faculty member participated in the following program(s)
“HIV-Associated Lipoatrophy – Management and Treatment Considerations1”
Gregory M. Lucas,
MD, PhD
Gregory M. Lucas, MD, PhD
Associate Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Johns Hopkins AIDS Services
This faculty member participated in the following program(s)
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on HIV”
Kieren A. Marr,
MD
Kieren A. Marr, MD
Professor of Medicine
Director, Transplant and Oncology Infectious Diseases Program
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Candida and Cryptococcus: The Epidemiology, Diagnosis, and Treatment of Medically Important Yeast”
“Aspergillus and Fusarium: The Epidemiology, Diagnosis, and Treatment of Medically Important Molds”
Nisa M. Maruthur,
MD, MHS
Nisa M. Maruthur, MD, MHS
Assistant Professor of Medicine and Epidemiology
Division of General Internal Medicine
Associate Director, General Internal Medicine Fellowship
Core Faculty, Welch Center for Prevention, Epidemiology and Clinical Research
Johns Hopkins University
This faculty member participated in the following program(s)
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”
Nestoras Mathioudakis,
MD
Nestoras Mathioudakis, MD
Assistant Director, Inpatient Diabetes Management Service
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”
Michael Melia,
MD
Michael Melia, MD
Instructor, Department of Medicine
The Johns Hopkins Hospital
This faculty member participated in the following program(s)
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on Antibiotics and Vaccines”
“48th Annual ICAAC®/IDSA 46th Annual Meeting Highlights on HIV”
“Clinical Updates in the Management of HIV from the 49th ICAAC® Conference”
Dionissios Neofytos,
MD, MPH
Dionissios Neofytos, MD, MPH
Assistant Professor of Medicine
Transplant and Oncology Infectious Diseases Program
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Candida and Cryptococcus: The Epidemiology, Diagnosis, and Treatment of Medically Important Yeast”
“Aspergillus and Fusarium: The Epidemiology, Diagnosis, and Treatment of Medically Important Molds”
Eric Nuermberger,
MD
Eric Nuermberger, MD
Assistant Professor of Medicine and International Health
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Skin and Soft Tissue Infections in Patients with Diabetes, including Cellulitis, Ulcers, and Osteomyelitis
Kathleen R. Page,
MD
Kathleen R. Page, MD
Assistant Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Johns Hopkins AIDS Services
This faculty member participated in the following program(s)
“Guidelines and Practice in Initiating Antiretroviral Therapy in 2011
Trish M. Perl,
MD, MSc
Trish M. Perl, MD, MSc
Professor of Medicine
Division of Infectious Diseases and Hospital Epidemiology and Infection Prevention
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“New Strategies for the Diagnosis and Treatment of Clostridium difficile Infection”
Paul A. Pham,
PharmD
Paul A. Pham, PharmD
Clinical Pharmacist
Research Associate
Johns Hopkins University School of Medicine
Division of Infectious Disease
This faculty member participated in the following program(s)
“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”
Richard E. Rothman,
MD, PhD, FACEP
Richard E. Rothman , MD, PhD, FACEP
Associate Professor of Emergency Medicine
Joint Appointment, Medicine Division of Infectious Diseases
Director of Research Department of Emergency Medicine
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“Epidemiology, Diagnosis, and Treatment in the Era of Community Onset MRSA, Prevention and Management of a Recurrent Infection”
Paul E. Sax,
MD
Paul E. Sax, MD
Clinical Director, HIV Program and Division of Infectious DiseasesBrigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
This faculty member participated in the following program(s)
“Initiation of Antiretroviral Therapy for HIV: Insights and Rationale”
Mark S. Sulkowski,
MD
Mark S. Sulkowski, MD
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Medical Director of the Viral Hepatitis Center in the Divisions of Infection Diseases, Gastroenterology and Hepatology
This faculty member participated in the following program(s)
“Management of Intersecting Epidemics: Metabolic Disorders and Liver Disease in HIV”
Aimee K. Zaas,
MD, MHS
Aimee K. Zaas, MD, MHS
Associate Professor of Medicine
Department of Medicine
Duke University Medical Center
Division of Infectious Diseases and International Health
This faculty member participated in the following program(s)
“Meeting the Challenge of Fungal Infection: Risk Assessment and the Role of Antifungal Agents”
Todd T. Brown, MD, Phd
Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Johns Hopkins University School of Medicine
This faculty member participated in the following program(s)
“HIV-Associated Lipoatrophy – Management and Treatment Considerations”
|
|
|
| |
Title: "Optimizing Patient Outcomes: Sequencing Therapy in Type 2 Diabetes – Part 1: Lifestyle Modifications and First-Line Agents”
Presented by: The Johns Hopkins University School of Medicine
Release Date: May 22, 2013
Expiration Date: May 22, 2014
Estimated time to complete each part of this activity: 30 minutes for each of the three activities. Each part of this activity has been approved for a maximum of 0.50 AMA PRA Category 1 Credit(TM). There are no fees or prerequisites.
Acknowledgement of Commercial Support: Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through a collaboration with Eli Lilly and Company.
|
|
 |
|
|
|
